Sfoglia per Rivista  CANCER

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 1 a 15 di 15
Titolo Data di pubblicazione Autore(i) File
Azacitidine for the treatment of lower risk myelodysplastic syndromes : a retrospective study of 74 patients enrolled in an Italian named patient program 2010 Musto, P., Maurillo, L., Spagnoli, A., Gozzini, A., Rivellini, F., Lunghi, M., Villani, O., Aloe-Spiriti, M.A., Venditti, A., Santini, V., Leone, G., Voso, M.T., D'Arco, A.M., Tatarelli, C., Ferrero, D., Gaidano, G., Palumbo, G., Di Raimondo, F., Oliva, E., Sanpaolo, G., Tonso, A., Santagostino, A., Filardi, N., Pollio, B., Candoni, A., Fili, C., Russo, D., Orciuolo, E., Petrini, M., Ciuffreda, L., Riezzo, A., Morabito, F., Mazza, P., Pastore, D., Specchia, G., Ferrara, F.
Characterization of a novel cell line from pleomorphic adenoma of the parotid gland with myoepithelial phenotype and producing interleukin-6 as an autocrine growth factor. 1992 O.GALLO; D.BANI; G.TOCCAFONDI; F.ALMERIGOGNA; O.FINI STORCHI.
Dermoscopic and histopathologic diagnosis of equivocal melanocytic skin lesions - An interdisciplinary study on 107 cases 2002 Ferrara, G.; Argenziano, G.; Soyer, H. P.; Corona, R.; Sera, F.; Brunetti, B.; Cerroni, L.; Chimenti, S.; El Shabrawi-Caelen, L.; Ferrari, A.; Hofmann-Wellenhof, R.; Kaddu, S.; Piccolo, D.; Scalvenzi, M.; Staibano, S.; Wolf, I. H.; De Rosa, G.
European Group for Blood and Marrow Transplantation and the European Leukemia Net. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. 2009 Gratwohl A; Stern M; Brand R; Apperley J; Baldomero H; de Witte T; Dini G; Rocha V; Passweg J; Sureda A; Tichelli A; Niederwieser D; Bosi A
Follicular Hurthle cell tumors of the thyroid gland 1991 Carcangiu; M.L.; Bianchi; S.; Savino; D.; Voynick; I.M.; Rosai; J.
Immunohistochemical evidence of immune responses to tumor-associated antigens in lymph nodes of colon carcinoma patients. 1991 Mariani-Costantini R; Muraro R; Ficari F; Valli C; Bei R; Tonelli F; Caramia F; Frati L.
In situ immunologic characterization of cutaneous involvement in Hodgkin's disease. 1989 S. Moretti; N. Pimpinelli; S. Di Lollo; C. Vallecchi; A. Bosi
Is there an optimal comorbidity index for prostate cancer? 2008 T.Cai; R.Bartoletti
Long term outcome of hematuria home screening for bladder cancer in men 2007 T.Cai; R.Bartoletti
Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin) +/- rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma. 2010 Rigacci, L; Fabbri, A; Puccini, B; Chitarrelli, I; Chiappella, A; Vitolo, U; Levis, A; Lauria, F; Bosi, Alberto
p-53-oncoprotein expression in parotid gland carcinoma is associated with clinical outcome. 1995 O. Gallo; A. Franchi; S. Bianchi; E. Giannelli; E. Alajmo.
Prognostic significance of false positive lymph nodes in patients with laryngeal cancer. 1995 O. Gallo; V. Boddi; G. V. Bottai; A. Franchi; O. Fini Storchi.
prognostic value of nuclear grading in intracapsular (pT1-pT2) renal cell carcinoma (RCC): Long-term analysis in 213 patients. 2002 Minervini A; Lilas L; Minervini R; Selli C.
Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcome. 1993 Ambrosetti A; Nadali G; Vinante F; Carlini S; Veneri D; Todeschini G; Morosato L; de Sabata D; Chilosi M; Maggi E; et al.
Sunitinib-induced hyperparathyroidism: A possible mechanism to altered bone homeostasis 2011 Baldazzi V; Tassi R; Lapini A; Lunghi A; Garofoli E; Caruso S; Carini M; Mazzanti R
Mostrati risultati da 1 a 15 di 15
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile